ArticleInfection and drug resistance2019
Characterization of a NDM-7 carbapenemase-producing
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Polyclonal carbapenemase-producingFrontiers in cellular and infection microbiology · 2025Article
- Molecular Characterization of Class 1 Integrons and Carbapenem-Resistant Genes in Enterobacter cloacae Complex Isolates.Current microbiology · 2024Article
- Molecular epidemiology and genomic insights into the transmission of carbapenem-resistant NDM-producingComputational and structural biotechnology journal · 2023Article
- Whole Genomic analysis of a clinical isolate of Uropathogenic Escherichia coli strain of Sequence Type - 101 carrying the drug resistance NDM-7 in IncX3 plasmid.Bioinformation · 2021Article
- Genotypic and Phenotypic Characterization ofFrontiers in microbiology · 2020Article
- Characterization of the IncX3 Plasmid ProducingFrontiers in microbiology · 2020Article
- Fecal Carriage and Molecular Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2020Article
- Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.PloS one · 2020Article
- Emergence of IncX3 Plasmid-HarboringFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.